IRIS
STEFANI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 60.095
AS - Asia 17.034
EU - Europa 6.561
SA - Sud America 1.223
AF - Africa 122
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 15
Totale 85.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 59.804
SG - Singapore 13.147
CN - Cina 1.343
IT - Italia 1.209
BR - Brasile 1.023
IE - Irlanda 971
RU - Federazione Russa 947
HK - Hong Kong 834
UA - Ucraina 825
DE - Germania 682
VN - Vietnam 601
FR - Francia 575
GB - Regno Unito 348
BD - Bangladesh 270
SE - Svezia 245
JP - Giappone 226
FI - Finlandia 203
PL - Polonia 171
CA - Canada 159
KR - Corea 151
NL - Olanda 130
IN - India 111
AR - Argentina 77
ID - Indonesia 69
MX - Messico 68
AT - Austria 49
ZA - Sudafrica 45
IQ - Iraq 44
ES - Italia 40
TR - Turchia 37
EC - Ecuador 29
BE - Belgio 27
CO - Colombia 26
PK - Pakistan 26
UZ - Uzbekistan 24
EU - Europa 23
VE - Venezuela 21
CZ - Repubblica Ceca 18
CL - Cile 17
MA - Marocco 17
SA - Arabia Saudita 16
MY - Malesia 15
PY - Paraguay 15
CH - Svizzera 14
EG - Egitto 14
KG - Kirghizistan 14
AU - Australia 13
JM - Giamaica 13
PH - Filippine 13
RO - Romania 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
IL - Israele 11
LT - Lituania 11
AL - Albania 10
TW - Taiwan 10
BG - Bulgaria 9
GR - Grecia 9
RS - Serbia 9
PE - Perù 8
TN - Tunisia 8
AZ - Azerbaigian 7
DK - Danimarca 7
NP - Nepal 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
CR - Costa Rica 6
GE - Georgia 6
HR - Croazia 6
IR - Iran 6
JO - Giordania 6
PT - Portogallo 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
HN - Honduras 5
LB - Libano 5
NI - Nicaragua 5
KZ - Kazakistan 4
NG - Nigeria 4
AO - Angola 3
BB - Barbados 3
BY - Bielorussia 3
DM - Dominica 3
ET - Etiopia 3
GD - Grenada 3
LA - Repubblica Popolare Democratica del Laos 3
PA - Panama 3
PR - Porto Rico 3
PS - Palestinian Territory 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
EE - Estonia 2
GT - Guatemala 2
HU - Ungheria 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
Totale 85.044
Salva come PNG Salva come JPEG
Città #
Wilmington 15.477
Houston 14.764
Woodbridge 13.791
Fairfield 2.189
Singapore 2.007
Ashburn 1.360
Ann Arbor 1.097
San Jose 1.018
Seattle 844
Hong Kong 827
Jacksonville 749
Cambridge 742
Chandler 712
Dublin 650
Beijing 528
Medford 493
Dearborn 408
Santa Clara 347
Rome 324
The Dalles 299
Council Bluffs 290
New York 277
Los Angeles 237
Lawrence 229
Tokyo 201
Lauterbourg 187
Hanoi 164
Ho Chi Minh City 159
Buffalo 154
Moscow 137
San Diego 115
Kraków 110
Menlo Park 109
Milan 105
Munich 101
São Paulo 99
London 87
Dallas 78
North Bergen 72
Helsinki 67
Chicago 60
Redondo Beach 58
Brooklyn 54
Mülheim 48
Phoenix 48
Atlanta 47
Warsaw 47
Amsterdam 45
Toronto 45
Norwalk 44
Orem 44
Montreal 43
Nuremberg 43
Jakarta 40
Shanghai 40
Redwood City 39
Zhengzhou 37
Stockholm 35
Chennai 34
Monte Vista 34
Johannesburg 32
Rio de Janeiro 32
Hefei 30
Boston 29
Verona 29
Boardman 28
Da Nang 28
Denver 28
Seoul 28
Belo Horizonte 26
Durham 26
Mexico City 26
Brussels 25
Manchester 25
Palo Alto 25
Kunming 24
St Louis 23
Salt Lake City 22
Falls Church 21
Haiphong 21
Nanjing 21
Elk Grove Village 20
Mountain View 20
Naples 20
University Park 19
Dhaka 17
Poplar 17
Frankfurt am Main 16
Guangzhou 16
Guarulhos 16
Ninh Bình 16
Salvador 16
San Francisco 16
Shenzhen 16
Tashkent 16
Biên Hòa 15
Brasília 15
Colorado Springs 15
Florence 15
Miano 15
Totale 63.354
Salva come PNG Salva come JPEG
Nome #
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process 636
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 617
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. 611
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease 603
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study. 603
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease? 599
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 596
Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine 594
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 592
Therapy for dyskinesias in Parkinson’s disease patients 591
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 588
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 571
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 566
Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson's disease 565
Posterior cortical atrophy with unilateral occipito-temporal degeneration 561
Reduced GABA Content in the Motor Thalamus during effective deep brain stimulation of the subthalamic nucleus 557
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 551
Motor and non-motor effects of PPN-DBS in PD patients: insights from intra-operative electrophysiology 551
Re: Stereotactic microdialysis of the basal ganglia in Parkinson's disease 549
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients 543
Effects of deep brain stimulation of the peduncolopontine area on working memory tasks in patients with Parkinson's disease 531
Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. 523
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 523
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 521
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 507
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 506
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease 503
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 494
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 493
Clinical and genetic study of a large SPG4 Italian family 492
Do CSF levels of t-Tau, p-Tau and beta(1-42) amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A I-123-FP-CIT study in the early stages of the disease 490
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease 489
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms 487
CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia 486
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. 483
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment 482
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 481
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration 480
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 477
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature 476
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 473
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease 473
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 473
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 472
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 471
Selective vulnerability of pallidal neurons in the early phases of manganese intoxication 470
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 468
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 466
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 466
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 464
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 462
Acute nigro-striatal blockade alters cortico-striatal encoding: An in vivo electrophysiological study 459
The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease 453
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 453
Distinct roles of cortical and pallidal β and γ frequencies in hemiparkinsonian and dyskinetic rats 452
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 451
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 449
Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients 447
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. 446
CSF biomarker variability in the Alzheimer's Association quality control program 444
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus 444
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 443
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 440
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation 440
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 438
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 436
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 436
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations 435
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 433
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease 433
Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study 430
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 429
Alexithymia is a non-motor symptom of Parkinson disease 428
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 426
Outward potassium currents activated by depolarization in rat globus pallidus 425
Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms 424
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 423
Thalamic ¹²³I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression 423
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 422
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 419
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 417
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 416
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 416
Pramipexole in comparison to l-dopa: a neuropsychological study 414
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 411
Theta Burst Stimulation Modulates Cerebellar-Cortical Connectivity in Patients with Progressive Supranuclear Palsy 410
Catecholamine-based treatment in AD patients: expectations and delusions 409
Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus: effects on gait in Parkinson's disease 408
The modulation of dopamine receptors in rat striatum 408
Basic research in substantia nigra and ventral tegmental area: clinical implications 408
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG. 407
The modulation of calcium currents by the activation of mGluRs. Functional implications 405
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 404
L-dopa modulates motor cortex excitability in Alzheimer's disease patients 401
Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on "CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease" by Lista et al 401
Deep brain stimulation in Parkinson's disease patients: biochemical evidence 399
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.(Reply from the authors) 395
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. 394
Psychiatric profile of motor subtypes of de novo drug-naïve Parkinson's disease patients 394
Cardiac rhabdomyosarcoma: a clinicopathologic and electron microscopy study 393
Totale 47.517
Salva come PNG Salva come JPEG
Categoria #
all - tutte 202.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 0 0 99
2021/20222.802 58 342 137 125 87 152 586 143 134 142 229 667
2022/20232.175 271 160 78 217 166 592 240 115 167 6 118 45
2023/2024855 90 33 63 18 85 143 36 144 22 53 14 154
2024/202515.405 171 1.254 584 330 113 471 464 357 642 527 6.024 4.468
2025/202611.134 814 382 1.173 924 887 350 1.325 1.466 1.228 1.181 924 480
Totale 86.226